Argent BioPharma Enters German Market with CannEpil® and CogniCann® Following Regulatory Approval

Argent BioPharma Ltd. , a clinical-stage biopharmaceutical company specializing in neuroimmune therapies, is pleased to announce its official entry into th...

April 24, 2025 | Thursday | News
Boehringer Ingelheim and Tessellate Bio Forge €500M Deal to Develop First-in-Class Oral Cancer Therapies Targeting ALT-Dependent Tumors

Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into ...

April 23, 2025 | Wednesday | News
Capricorn Scientific and florabio Partner to Advance Animal-Free, High-Yield Cell Culture Solutions

Animal-free, high-yield solutions for scalable production Strategic partnership accelerating innovation from lab to GMP scale Breakthrough media for ...

April 21, 2025 | Monday | News
Eisai and Biogen’s Leqembi® Becomes First Alzheimer’s Therapy Approved in EU to Target Disease Pathology

Eisai Co., Ltd. and Biogen Inc. announced that the European Commission (EC) has granted marketing authorization (MA) for Leqembi® (lecanemab), a m...

April 17, 2025 | Thursday | News
Atelerix Partners with MineBio to Launch Cryo-Free Cell Preservation Technology in China

Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network Hypothermic pres...

April 16, 2025 | Wednesday | News
Lecanemab Becomes First Approved Disease-Modifying Therapy for Early Alzheimer’s in the EU

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild de...

April 16, 2025 | Wednesday | News
Meribel Pharma Solutions Launches as Mid-Size European CDMO with 13 Sites Across France, Spain, and Sweden

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network ...

April 15, 2025 | Tuesday | News
Boehringer Ingelheim and Cue Biopharma Partner to Advance First-in-Class B Cell Depletion Therapy for Autoimmune Diseases

Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The ...

April 15, 2025 | Tuesday | News
Sanofi Expands Respiratory Pipeline With Promising Asthma Data and New COPD Study Plans

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show ...

April 15, 2025 | Tuesday | News
Lonza Joins CMAC to Advance Digital and Continuous Manufacturing Capabilities

Lonza joined CMAC to enhance its service offering for specialty and enhanced drug product and particle technologies   Lonza will ser...

April 15, 2025 | Tuesday | News
Roche Secures EU Approval for Columvi Combo as First Bispecific Antibody Regimen for Relapsed DLBCL

Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThe...

April 14, 2025 | Monday | Regulatory
FDA Clears argenx SE’s VYVGART Hytrulo Prefilled Syringe for Patient Self-Injection

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the U.S. Food a...

April 11, 2025 | Friday | News
Cellistic Introduces Echo™-NK Platform to Power Scalable Off-the-Shelf NK Cell Therapies for Cancer and Autoimmune Diseases

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manuf...

April 11, 2025 | Friday | News
Seegene Unveils Vision for Next-Gen PCR Automation with CURECA™ System

Seegene Inc., a global leader in molecular diagnostics (MDx), is advancing its vision for innovation in laboratory automation with the development of ...

April 10, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close